| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uremia | D014511 | 33 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neoplasms, Experimental | D009374 | 10 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Shalhoub V et al. | Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. | 1999 | J. Cell. Biochem. | pmid:10022507 |
| Hsu H et al. | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10097072 |
| Nagai M and Sato N | Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10208850 |
| Burgess TL et al. | The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | 1999 | J. Cell Biol. | pmid:10225954 |
| Kong YY et al. | Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. | 1999 | Immunol. Cell Biol. | pmid:10234557 |
| Yano K et al. | Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. | 1999 | J. Bone Miner. Res. | pmid:10234572 |
| Zhang XD et al. | Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. | 1999 | Cancer Res. | pmid:10364001 |
| Spelsberg TC et al. | The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. | 1999 | Mol. Endocrinol. | pmid:10379881 |
| Yasuda H et al. | A novel molecular mechanism modulating osteoclast differentiation and function. | 1999 | Bone | pmid:10423033 |
| Roodman GD | Cell biology of the osteoclast. | 1999 | Exp. Hematol. | pmid:10428500 |
| Lee SK and Lorenzo JA | Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. | 1999 | Endocrinology | pmid:10433211 |
| Ito H et al. | Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10462495 |
| Hofbauer LC et al. | Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. | 1999 | Endocrinology | pmid:10465311 |
| Morony S et al. | A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. | 1999 | J. Bone Miner. Res. | pmid:10469275 |
| Sakata M et al. | Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. | 1999 | J. Bone Miner. Res. | pmid:10469276 |
| Lazner F et al. | Osteopetrosis and osteoporosis: two sides of the same coin. | 1999 | Hum. Mol. Genet. | pmid:10469835 |
| Hofbauer LC | Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. | 1999 | Eur. J. Endocrinol. | pmid:10474114 |
| Wickelgren I | Mining the genome for drugs. | 1999 | Science | pmid:10475849 |
| Hofbauer LC et al. | Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. | 1999 | Endocrinology | pmid:10499489 |
| Thomas RJ et al. | Breast cancer cells interact with osteoblasts to support osteoclast formation. | 1999 | Endocrinology | pmid:10499498 |
| Itonaga I et al. | 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10529407 |
| Nakagawa N et al. | Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548488 |
| Nakagawa N et al. | Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548507 |
| Kong YY et al. | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. | 1999 | Nature | pmid:10580503 |
| Yamashita T et al. | Retardation in bone resorption after bone marrow ablation in klotho mutant mice. | 2000 | Endocrinology | pmid:10614667 |
| Itonaga I et al. | Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. | 2000 | Ann. Rheum. Dis. | pmid:10627423 |
| Chikatsu N et al. | Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10631114 |
| Hofbauer LC et al. | The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | 2000 | J. Bone Miner. Res. | pmid:10646108 |
| Tricot G | New insights into role of microenvironment in multiple myeloma. | 2000 | Lancet | pmid:10675068 |
| Makhluf HA et al. | Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10679262 |
| Merewether LA et al. | Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. | 2000 | Arch. Biochem. Biophys. | pmid:10683254 |
| Takayanagi H et al. | Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. | 2000 | Arthritis Rheum. | pmid:10693864 |
| Huang L et al. | Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. | 2000 | Am. J. Pathol. | pmid:10702390 |
| Capparelli C et al. | Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. | 2000 | Cancer Res. | pmid:10706080 |
| Ross FP | RANKing the importance of measles virus in Paget's disease. | 2000 | J. Clin. Invest. | pmid:10712423 |
| Bateman TA et al. | Osteoprotegerin mitigates tail suspension-induced osteopenia. | 2000 | Bone | pmid:10773583 |
| Mukohyama H et al. | The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10777696 |
| Atkins GJ et al. | Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. | 2000 | J. Bone Miner. Res. | pmid:10780856 |
| Aubin JE and Bonnelye E | Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. | 2000 | Medscape Womens Health | pmid:10792853 |
| Thompson SW and Tonge D | Bone cancer gain without the pain. | 2000 | Nat. Med. | pmid:10802700 |
| Honore P et al. | Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. | 2000 | Nat. Med. | pmid:10802707 |
| Onyia JE et al. | In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. | 2000 | J. Bone Miner. Res. | pmid:10804015 |
| Malyankar UM et al. | Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. | 2000 | J. Biol. Chem. | pmid:10811631 |
| Kanzawa M et al. | Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. | 2000 | Eur. J. Endocrinol. | pmid:10822231 |
| Thirunavukkarasu K et al. | The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. | 2000 | J. Biol. Chem. | pmid:10833509 |
| Günther T and Schinke T | Mouse genetics have uncovered new paradigms in bone biology. | 2000 | Trends Endocrinol. Metab. | pmid:10856921 |
| Rani CS and MacDougall M | Dental cells express factors that regulate bone resorption. | 2000 | Mol. Cell Biol. Res. Commun. | pmid:10860862 |
| Tsurukai T et al. | Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. | 2000 | J. Bone Miner. Metab. | pmid:10874596 |
| Hofbauer LC and Heufelder AE | Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. | 2000 | J. Clin. Endocrinol. Metab. | pmid:10902778 |